Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

STRATA Skin Sciences (SSKN) EBT (2016 - 2025)

STRATA Skin Sciences' EBT history spans 14 years, with the latest figure at $3.5 million for Q4 2025.

  • On a quarterly basis, EBT rose 173.19% to $3.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.9 million, a 74.27% increase, with the full-year FY2025 number at -$6.2 million, up 39.55% from a year prior.
  • EBT hit $3.5 million in Q4 2025 for STRATA Skin Sciences, up from -$1.6 million in the prior quarter.
  • Over the last five years, EBT for SSKN hit a ceiling of $3.5 million in Q4 2025 and a floor of -$4.7 million in Q4 2024.
  • Historically, EBT has averaged -$1.6 million across 5 years, with a median of -$2.0 million in 2022.
  • Biggest five-year swings in EBT: plummeted 3906.19% in 2023 and later skyrocketed 173.19% in 2025.
  • Tracing SSKN's EBT over 5 years: stood at -$827000.0 in 2021, then skyrocketed by 88.27% to -$97000.0 in 2022, then plummeted by 3906.19% to -$3.9 million in 2023, then decreased by 21.59% to -$4.7 million in 2024, then surged by 173.19% to $3.5 million in 2025.
  • Business Quant data shows EBT for SSKN at $3.5 million in Q4 2025, -$1.6 million in Q3 2025, and -$2.6 million in Q2 2025.